Epirubicin hydrochloride

• Category :

  Intermediates/Pharmaceutical intermediates

• Synonyms :

  epirubicin hydrochloride;l-erythro-dihydrosphingosine;(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-arabino-hexopyranoside hydrochloride (1:1);(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-beta-L-arabino-hexopyranoside;

• CAS NO :

  56390-09-1

• EC NO :

  260-145-2

• Molecular Formula :

  C₂₇H₂₉NO₁₁

• Molecular Weight :

  543.5193

• Main Specifications :

• InChI :

  InChI=1/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17+,22-,27-/m0/s1

• Uses :

  Monotherapy has broad-spectrum inhibition against a wide range of tumors, including breast cancer, malignant lymphoma, soft tissue sarcoma, and gastric cancer. Studies have shown that the drug also has anti-tumor activity against malignant melanoma and co

• Molecular Structure :